J&J sales increase 4% in Q3: 4 things to know

New Brunswick, N.J.-based Johnson & Johnson reported $17.8 billion in sales for the third quarter of 2016, a 4.2 percent increase from the same period last year.

Here are four things to know.

  1. In the third quarter of 2016, J&J's global sales increased by 5.9 percent, domestic sales jumped by 7.3 percent and international sales rose by 4.2 percent, excluding the net impact of acquisitions, divestitures and hepatitis C sales.

  2. Operational sales results jumped 4.3 percent in the third quarter of 2016, compared to the same period the year prior.

  3. J&J's net earnings and diluted earnings per share for the third quarter of 2016 were $4.3 billion and $1.53, respectively, according to the report.

  4. J&J projects sales of $71.5 to $72.2 billion for the full 2016 year.

More articles on supply chain:

NeoGrid expands supply chain services: 3 things to know
Prescription drug costs see largest jump in 24 years
Texas Medical Center partners with J&J to develop medical devices

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars